Get started
Work

Effect of Tiotropium on Outcomes in Patients With COPD, Categorized Using the New GOLD Grading System: Results of the UPLIFT® Randomized Controlled Trial

Year: 2015
Type: article
Abstract: = 0.4978). The incidence rate of major adverse cardiac events was higher in Group D than in Groups A-C but lower within the group in patients treated with tiotropium. In conclusion, tiotropium improved lung function and health status, and reduced exacerbation rates in patients in all GOLD groups.
DOI: 10.15326/jcopdf.2.3.2014.0142
Authors: David Halpin, Donald Tashkin, Bartolome Celli, Inge Leimer, Norbert Metzdorf, Marc Decramer
Institutions: Royal Devon and Exeter Hospital, Royal Devon University Healthcare NHS Foundation Trust, University of California, Los Angeles, Brigham and Women's Hospital, Boehringer Ingelheim (Germany), KU Leuven
Language: English
Field: Medicine
Open Access status: diamond
Funder: Pfizer
OpenAlex ID: W3021392565
FWCI: 0.264
Cites: 17
Cited by: 3
Related to: 10